Hinrikson H P, Dutly F, Altwegg M
Department of Medical Microbiology, University of Zürich, CH-8028 Zürich, Switzerland.
J Clin Microbiol. 2000 Feb;38(2):595-9. doi: 10.1128/JCM.38.2.595-599.2000.
"Tropheryma whippelii"-associated infections are usually confirmed histopathologically by using light microscopy. PCR assays targeting the 16S rRNA gene (16S rDNA) of "T. whippelii" are increasingly being applied for this purpose. Compared to microscopic analysis, PCR seems to be more sensitive, as indicated by the fact that several cases of Whipple's disease with negative histopathological findings but positive PCR results have been reported. Considering the lack of pathognomonic clinical features for this disease and the fact that "T. whippelii" DNA has repeatedly been found in patients without clinical Whipple's disease, such PCR results should be confirmed by additional tests. We have, therefore, evaluated a "T. whippelii"-specific nested PCR targeting domain III of the 23S rDNA with 41 clinical specimens known to contain "T. whippelii" 16S rDNA. All of these specimens were also positive for "T. whippelii" 23S rDNA. The specificity of the test was shown by sequencing of the amplicons and by the absence of amplicons in 38 negative controls. We consider this PCR test to be a suitable tool for confirming the presence of "T. whippelii" DNA in specimens with inconclusive histopathological findings. The information derived from sequencing of the partial "T. whippelii" 23S rDNA was then combined with our recent data of the 16S-23S rDNA spacer region of this organism. Overall, four different rDNA types are recognized in our proposed classification system for molecular variants of "T. whippelii." This preliminary scheme may provide a basis for further epidemiological and clinical studies with "T. whippelii" and associated diseases.
与“惠普尔嗜组织菌”(Tropheryma whippelii)相关的感染通常通过光学显微镜进行组织病理学确诊。针对“惠普尔嗜组织菌”16S rRNA基因(16S rDNA)的聚合酶链反应(PCR)检测正越来越多地用于此目的。与显微镜分析相比,PCR似乎更敏感,因为已有报道称几例惠普尔病组织病理学检查结果为阴性但PCR结果为阳性。鉴于该疾病缺乏特征性临床症状,且在无临床惠普尔病的患者中反复发现“惠普尔嗜组织菌”DNA,此类PCR结果应通过其他检测加以证实。因此,我们用41份已知含有“惠普尔嗜组织菌”16S rDNA的临床标本,对靶向23S rDNA第三结构域的“惠普尔嗜组织菌”特异性巢式PCR进行了评估。所有这些标本的“惠普尔嗜组织菌”23S rDNA检测也均为阳性。通过对扩增子进行测序以及在38份阴性对照中未检测到扩增子,证明了该检测的特异性。我们认为该PCR检测是一种适用于在组织病理学检查结果不明确标本中确认“惠普尔嗜组织菌”DNA存在的工具。然后,将部分“惠普尔嗜组织菌”23S rDNA测序获得的信息与我们最近关于该菌16S - 23S rDNA间隔区的数据相结合。总体而言,在我们提出的“惠普尔嗜组织菌”分子变体分类系统中识别出四种不同的rDNA类型。这一初步方案可为进一步开展关于“惠普尔嗜组织菌”及相关疾病的流行病学和临床研究提供基础。